DVx Inc. Announces Consolidated Earnings Results for the Six Months Ended September 30, 2015; Provides Dividend Forecast for the Fiscal Year Ending March 31, 2016; Provides Earnings Forecast for the Fiscal Year Ending March 31, 2016
November 02, 2015 at 10:00 am EST
Share
DVx Inc. announced consolidated earnings results for the six months ended September 30, 2015. For the period, the group reported net sales of ¥14,753 million, operating income of ¥592 million, ordinary income of ¥586 million and net income of ¥702 million or ¥62.33 per share compared to net sales of ¥14,204 million, operating income of ¥716 million, ordinary income of ¥726 million and net income of ¥462 million or ¥40.98 per share reported in the same period last year. Net cash provided by operating activities was ¥632,626,000 against ¥153,265,000 a year ago. Purchase of property plant and equipment was ¥77,111,000 against ¥35,198,000 a year ago. Purchase of intangible assets was ¥17,402,000 against ¥30,876,000 a year ago. Income before income taxes was ¥1,040,446,000 against ¥726,040,000 a year ago.
For the fiscal year ending March 31, 2016, the company reported year end dividend forecast of ¥23.00 per share compared to ¥18.00 per share declared last year.
For the year ending March 31, 2016, the group expected to report net sales of ¥31,589 million, operating income of ¥1,530 million, ordinary income of ¥1,530 million and net income of ¥1,289 million or ¥114.39 per share.
DVx Inc. is a Japan-based company mainly engaged in the sale of medical equipment for circulatory system diseases. The Company operates in two business segments. The Arrhythmia segment mainly sells cardiac pacemakers, implantable cardioverter-defibrillators (ICDs), electrode catheters and ablation catheters. The Ischemia segment is engaged in the import and sale of automated contrast medium injectors under the name ACIST, excimer laser angioplasty systems, as well as sale of coronary artery stent products as agency business. The others business is engaged in the sale of neurosurgical products, general surgery related products, gastrointestinal related products, radiation protection supplies, among others.
DVx Inc. Announces Consolidated Earnings Results for the Six Months Ended September 30, 2015; Provides Dividend Forecast for the Fiscal Year Ending March 31, 2016; Provides Earnings Forecast for the Fiscal Year Ending March 31, 2016